Stem Cells Spin (WAR:SCS) ROA %: -7.13% (As of Mar. 2026)


WAR:SCS Stem Cells Spin SA WAR:SCS
25 GF Score
Price zł0.40
GF Value zł0.10
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Stem Cells Spin ROA %?

Stem Cells Spin WAR:SCS 25 ROA % is -7.13% as of Mar. 2026. GuruFocus rates WAR:SCS with a GF Score™ of 25/100 and a GF Value™ of zł0.10 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 1,417 Biotechnology companies, Stem Cells Spin ranks better than 74.52% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Stem Cells Spin's annualized Net Income for the quarter that ended in Mar. 2026 was zł-0.67 Mil. Stem Cells Spin's average Total Assets over the quarter that ended in Mar. 2026 was zł9.36 Mil. Therefore, Stem Cells Spin's annualized ROA % for the quarter that ended in Mar. 2026 was -7.13%.

The historical rank and industry rank for Stem Cells Spin's ROA % or its related term are showing as below:

WAR:SCS' s ROA % Range Over the Past 10 Years
Min: -5.55   Med: -0.93   Max: 0.59
Current: -5.55

During the past 13 years, Stem Cells Spin's highest ROA % was 0.59%. The lowest was -5.55%. And the median was -0.93%.

WAR:SCS's ROA % is ranked better than
74.52% of 1417 companies
in the Biotechnology industry
Industry Median: -32.84 vs WAR:SCS: -5.55

Stem Cells Spin  (WAR:SCS) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=-0.668/9.3625
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.668 / 0.028)*(0.028 / 9.3625)
=Net Margin %*Asset Turnover
=-2385.71 %*0.003
=-7.13 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Stem Cells Spin ROA % Related Terms


Stem Cells Spin ROA % Historical Data

* Premium members only.

The historical data trend for Stem Cells Spin's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stem Cells Spin ROA % Chart

Stem Cells Spin Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.77 0.17 -1.08 -4.22 -5.11

Stem Cells Spin Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.95 -4.66 -4.63 -5.95 -7.13

WAR:SCS vs VRTX, REGN, ALNY: ROA % Comparison

For the Biotechnology subindustry, Stem Cells Spin's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stem Cells Spin ROA % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Stem Cells Spin's ROA % distribution charts can be found below:

* The bar in red indicates where Stem Cells Spin's ROA % falls into.


WAR:SCS
25GF Score
Stem Cells Spin SA WAR:SCS
ROA % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stem Cells Spin ROA % Calculation

Stem Cells Spin's annualized ROA % for the fiscal year that ended in Dec. 2025 is calculated as:

ROA %=Net Income (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=-0.526/( (11.023+9.575)/ 2 )
=-0.526/10.299
=-5.11 %

Stem Cells Spin's annualized ROA % for the quarter that ended in Mar. 2026 is calculated as:

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-0.668/( (9.575+9.15)/ 2 )
=-0.668/9.3625
=-7.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of -7.13% mean?
Stem Cells Spin (WAR:SCS) has a ROA % of -7.13% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Stem Cells Spin and its competitors. According to the industry distribution chart, Stem Cells Spin ranks #361 out of 1417 companies in the Biotechnology industry, placing it in the top 25.5%.
Is Stem Cells Spin's ROA % too high?
Stem Cells Spin's current ROA % is -7.13%. Based on the distribution chart, Stem Cells Spin ranks #361 out of 1417 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Stem Cells Spin has a GF Score™ of 25/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Stem Cells Spin's ROA % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Stem Cells Spin ranks #361 out of 1417 companies for ROA %. This puts Stem Cells Spin in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Biotechnology company?
A good ROA % depends on the Biotechnology industry context. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Stem Cells Spin and its competitors. Stem Cells Spin's current ROA % is -7.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stem Cells Spin stock overvalued right now?
Based on GuruFocus' analysis, Stem Cells Spin (WAR:SCS) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.10, compared to a current price of zł0.40 — trading 300% above its estimated fair value. The current ROA % is -7.13%. Stem Cells Spin's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Stem Cells Spin (WAR:SCS), the current ROA % is -7.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stem Cells Spin (WAR:SCS) Overvalued in 2026?

Based on GuruFocus' analysis, Stem Cells Spin stock appears to be overvalued. The current stock price of zł0.40 is trading 300% above its estimated GF Value™ of zł0.10. GuruFocus considers Stem Cells Spin to be Significantly Overvalued.

Key valuation signals for WAR:SCS:

  • ROA %: -7.13%
  • GF Value™: zł0.10 vs. price of zł0.40 (300% above fair value)
  • GF Score™: 25/100 with 3 warning signs

No single metric tells the full story. See the WAR:SCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stem Cells Spin Business Description

Address Ulica Konopnickiej 15 b, Wroclaw, POL, 51-141
Stem Cells Spin SA is a biotechnology company. The company is engaged in the development, production, marketing, and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. Its products include NHAC Biocervin MIC-1, Revitacell, PRS MIC-1, and Velvetyna.
25GF Score

Get the complete analysis for WAR:SCS

ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.40
Price
zł0.10
GF Value